Feenstra TL - Search Results

1

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.

Hoogenveen RT, van Baal PH, Boshuizen HC, Feenstra TL. Hoogenveen RT, et al. Among authors: feenstra tl. Cost Eff Resour Alloc. 2008 Jan 11;6:1. doi: 10.1186/1478-7547-6-1. Cost Eff Resour Alloc. 2008. PMID: 18190684 Free PMC article.

2

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: feenstra tl. Thorax. 2010 Aug;65(8):711-8. doi: 10.1136/thx.2009.131631. Thorax. 2010. PMID: 20685746 Free article. Review.

3

If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.

Vemer P, Rutten-van Mölken MP, Kaper J, Hoogenveen RT, van Schayck CP, Feenstra TL. Vemer P, et al. Among authors: feenstra tl. Addiction. 2010 Jun;105(6):1088-97. doi: 10.1111/j.1360-0443.2010.02901.x. Addiction. 2010. PMID: 20659063 Clinical Trial.

4

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio.

van Baal PH, Feenstra TL, Hoogenveen RT, de Wit GA, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. Health Econ. 2007 Apr;16(4):421-33. doi: 10.1002/hec.1181. Health Econ. 2007. PMID: 17039573

5

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.

van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. PLoS Med. 2008 Feb;5(2):e29. doi: 10.1371/journal.pmed.0050029. PLoS Med. 2008. PMID: 18254654 Free PMC article.

6

Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness.

Over EA, Feenstra TL, Hoogenveen RT, Droomers M, Uiters E, van Gelder BM. Over EA, et al. Among authors: feenstra tl. Nicotine Tob Res. 2014 Jun;16(6):725-32. doi: 10.1093/ntr/ntt218. Epub 2014 Jan 4. Nicotine Tob Res. 2014. PMID: 24388862

7

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention.

Feenstra TL, van Baal PM, Jacobs-van der Bruggen MO, Hoogenveen RT, Kommer GJ, Baan CA. Feenstra TL, et al. Cost Eff Resour Alloc. 2011 Oct 6;9(1):14. doi: 10.1186/1478-7547-9-14. Cost Eff Resour Alloc. 2011. PMID: 21974836 Free PMC article.

8

Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease.

Eussen SR, Feenstra TL, Toxopeus IB, Hoekstra J, Klungel OH, Verhagen H, van Kranen HJ, Rompelberg CJ. Eussen SR, et al. Among authors: feenstra tl. Eur J Pharmacol. 2011 Sep;668 Suppl 1:S91-100. doi: 10.1016/j.ejphar.2011.05.081. Epub 2011 Jul 27. Eur J Pharmacol. 2011. PMID: 21816151 Review.

9

Economic evaluation and the postponement of health care costs.

van Baal PH, Feenstra TL, Polder JJ, Hoogenveen RT, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. Health Econ. 2011 Apr;20(4):432-45. doi: 10.1002/hec.1599. Health Econ. 2011. PMID: 21210494

10

Cost-effectiveness of lifestyle modification in diabetic patients.

Jacobs-van der Bruggen MA, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens EJ, Baan CA. Jacobs-van der Bruggen MA, et al. Among authors: feenstra tl. Diabetes Care. 2009 Aug;32(8):1453-8. doi: 10.2337/dc09-0363. Epub 2009 May 12. Diabetes Care. 2009. PMID: 19435958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results